Stay updated on Avapritinib in Advanced Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.

Latest updates to the Avapritinib in Advanced Mastocytosis Clinical Trial page
- CheckyesterdayChange DetectedThe page has removed the phrase 'Last Update Posted (Estimated)' and replaced it with 'Last Update Posted'.SummaryDifference0.0%
- Check9 days agoChange DetectedThe webpage has been updated with new completion dates and a revision number, indicating a significant update to the content. The previous version's dates and revision number have been removed.SummaryDifference2%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding avapritinib (BLU-285) and its clinical trial criteria, while adding a new revision number.SummaryDifference20%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Avapritinib in Advanced Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.